Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Biosun Biotech, also known as Baichen Medical, is a leading Chinese medical technology company specializing in the clinical application of mass spectrometry. The company provides a comprehensive ecosystem for precision medicine, including proprietary liquid chromatography-tandem mass spectrometry (LC-MS/MS) instruments, automated sample pretreatment systems, and a diverse portfolio of certified reagent kits. Their solutions are primarily utilized for therapeutic drug monitoring, newborn screening, and nutritional assessment in clinical laboratories and hospitals. By integrating hardware, software, and diagnostic reagents, Biosun Biotech facilitates the standardization of high-end analytical techniques for routine clinical use. Headquartered in Hangzhou, the company is a key player in the transition from traditional immunoassays to more precise mass spectrometry-based diagnostics in the Chinese market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Biosun Biotech.